Showing 4 of 4 recruiting trials for “Autosomal recessive polycystic kidney disease”
RecruitingNCT07201025 ↗
Imaging Assessments of ARPKD Kidney Disease Progression
RecruitingNCT06601829 ↗
Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
🏥 Otsuka Pharmaceutical Development & Commercialization, Inc.📍 23 sites📅 Started Jan 2023View details ↗
RecruitingNCT01401998 ↗
ARPKD Database Study
👨⚕️ Lisa Guay-Woodford, MD, Children's Hospital of Philadelphia📍 6 sites📅 Started Jun 2011View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →